Skip to main content
Article thumbnail
Location of Repository

The Haemopoietic Stem Cell: Between Apoptosis and Self Renewal

By Faris Q. Alenzi, Badi Q. Alenazi, Shamweel Y. Ahmad, Mohamed L. Salem, Ali A. Al-Jabri and Richard K.H. Wyse

Abstract

Self renewal and apoptosis of haemopoietic stem cells (HSC) represent major factors that determine the size of the haemopoietic cell mass. Changes in self renewal above or below the steady state value of 0.5 will result in either bone marrow expansion or aplasia, respectively. Despite the growing body of research that describes the potential role of HSC, there is still very little information on the mechanisms that govern HSC self renewal and apoptosis. Considerable insight into the role of HSC in many diseases has been gained in recent years. In light of their crucial importance, this article reviews recent developments in the understanding of the molecular, biological, and physiological characteristics of haemopoietic stem cells

Topics: Review
Publisher: Yale Journal of Biology and Medicine
OAI identifier: oai:pubmedcentral.nih.gov:2660591
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (IL-3), but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitro.
    2. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research.
    3. (2006). Aging at the interface of stem cell renewal, apoptosis, senescence, and cancer. SciAging Knowl Environ.
    4. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis.
    5. Bax suppresses tumorigenesis and stimulates apoptosis in vivo.
    6. BCR-ABL oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 1988;3:387-99. 17 Alenzi: Haemopoietic stem cell83. Mandanas
    7. Becker MW,Wicha M,Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev.
    8. (1992). Botanical musings. Exp Hematol.
    9. CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein.
    10. Characterization and partial purification of human marrow cells capable of initiating long term hematopoiesis in vitro.
    11. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects.
    12. (1994). Cytokines acting on committed haematopoietic progenitors. Baillieres Clin Haematol.
    13. Differentiation and proliferation of hematopoietic stem cells.
    14. (1998). Do stem cells play dice?
    15. DomenJ,CheshierSH,WeissmanIL.Therole ofapoptosisintheregulationofhematopoietic stem cells: Overexpression of Bcl-2 increases boththeir numberandrepopulationpotential.
    16. (1979). Erythroid progenitor cells: their relevance for the study of haematological disease. Clin Hematol.
    17. Erythropoiesis in culture. Clin Haematol.
    18. et al.Apoptosis and proliferation (PCNA labelling) in CML, a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
    19. (1996). Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med.
    20. (1997). Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol.
    21. (1997). Expression of an L-selectin ligand on hematopoietic progenitor cells. Acta Haematol.
    22. (1994). Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism.
    23. (2007). Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol.
    24. (1990). Expression of the CD34 gene in vascular endothelial cells.
    25. Expression of Thy-1 on human hematopoietic progenitor cells.
    26. (1995). Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.
    27. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells.
    28. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells.
    29. Fas-mediated modulation of BCR-ABL in chronic myelogenous leukemia results in differential effects on apoptosis.
    30. FoxO3a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or aging.
    31. (1995). Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells.
    32. (1998). Functional expression of Fas on mouse bone marrow stromal cells: Upregulation by tumor necrosis factor. Exp Hematol.
    33. Gordon MY.The kinetics of colony formation by CFU-GM in vitro.
    34. (2002). Gorski KS.Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation.
    35. (1990). Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis.
    36. (2007). Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2. Mol Cell Biol.
    37. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice.
    38. Hematopoietic stem cells need two signals to prevent apoptosis;
    39. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.
    40. (1993). Human haemopoietic stem cell assays. Blood Rev.
    41. Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.
    42. IL.The long term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype.
    43. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice.
    44. (1995). Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    45. Isolation of a candidate human hematopoietic stem-cell population.
    46. (2007). Life and death in hematopoietic stem cells. Curr Opin Immunol.
    47. (1998). Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation.
    48. Links between apoptosis, cell cycle and proliferation.
    49. (1996). Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
    50. (1991). Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen re16 Alenzi: Haemopoietic stem cellactive B cells in vitro and in vivo.
    51. (1998). Mice defective in two apoptosis pathways in themyeloidlineagedevelopacutemyeloblastic leukemia.
    52. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1.
    53. Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells. Stem Cells.
    54. (1998). PaolucciE,StornaiuoloA,etal.Muscleregeneration by bone marrow-derived myogenic progenitors.
    55. (2001). Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid progenitor cell self-renewal kinetics. Bone Marrow Transplant.
    56. (1992). Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol.
    57. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol.1998;26:53-62.
    58. (1998). Protein tyrosine kinase receptor signalling decreases progenitor cell self replication.
    59. Regulation of haemopoietic progenitor cell number by the Fas/FasL apoptotic mechanism. Exp Hematol.
    60. (1989). Regulation of megakaryocytopoiesis.
    61. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal.
    62. Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events.
    63. (2004). Relationships between stem cells and cancer stem cells. Histol Histopathol.
    64. Replicative stress, stem cells and aging. Mech Ageing Dev.
    65. Routes to repopulation — a unification of the stochastic model and separation of stem-cell subpopulations.
    66. Self-renewal and solid tumor stem cells.
    67. Selfrenewal of hemopoietic stem cells during mixed colony formation in vitro.
    68. Selfrenewalofmultipotentlong-termrepopulating hematopoietic stem cells is negatively regulatedbyFasandtumornecrosisfactorreceptor activation.
    69. (1997). Shah NM,Anderson DJ. Regulatory mechanisms in stem cell biology.
    70. Siminovitch L.Astochastic model of stem cell proliferation, based on the growth of spleen colony-forming units.
    71. (2004). Stem cells — biology and therapeutic application. Postepy Hig Med Dosw.
    72. Stem cells and brain cancer.
    73. Stem cells and the rate of living.
    74. Stem cells in normal and leukemic hemopoiesis.
    75. Stem cells in normal breast development and breast cancer. Cell Prolif.
    76. (1997). Stem cells: characterization and measurement. Baillieres Clin Haematol.
    77. (1994). Stochastic effects in hemopoiesis. Stem Cells.
    78. Stochastic versus deterministic in haemopoiesis: what is what?
    79. (1995). Structural and signaling requirements for BCRABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol.
    80. SudaT, Ogawa M.Analysis of differentiation of mouse hemopoietic stem cell in cultures by sequential replating of paired progenitors.
    81. (1991). The blueness of stem cells. Exp Hematol.
    82. The identification of colony-forming cells among spleen colonies.
    83. The production of committed hemopoietic colony-forming cells from multipotential precursor cells in vitro.
    84. (1993). The stochastic blueness of leukemic stem cells in experimental antineoplastic therapy. Exp Hematol.
    85. Transfection of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemiaspecific P210 protein.
    86. (1998). Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocytemacrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    87. (1992). Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: Role of colony-stimulating factor receptor modulation. J Exp Med.
    88. Zfx controls the self-renewal of embryonic and hematopoietic stem cells.
    89. (1999). Zhang XL,Azuma E,Yamamoto H, Sakurai M. Expression of homing-associated cell adhesion molecule (H-CAM/CD44) on human CD34+ hematopoietic progenitor cells. Exp Hematol.
    90. Zon LI.The clinical potential of stem cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.